Document is current
Any future updates will be listed below
-
Authors
Verheugt, F. W. A.
Damman, P.
Damen, S. A. J.
Wykrzykowska, J. J.
Woelders, E. C. I.
van Geuns, R. -J. M.
-
Funding
Funding for this research was provided by:
none
- License Information
-
More Information
Article History
Accepted: 3 May 2021
First Online: 8 June 2021
Conflict of interest
: F.W.A. Verheugt has received honoraria for consulting and presentations from AstraZeneca, Bayer Healthcare and Daiichi-Sankyo. P. Damman has received consultancy fees from Philips and Abbott, and research grants from Philips, Abbott and AstraZeneca. R.-J.M. van Geuns reports personal fees from Abbott vascular, grants and personal fees from AstraZeneca, grants and personal fees from Amgen, grants and personal fees from Boston Scientific, and personal fees from Sanofi. S.A.J. Damen, J.J. Wykrzykowska and E.C.I. Woelders declare that they have no competing interests.
